United Therapeutics Corp. (UTHR)

$ 309.72
   
  • Change Today:
    $8.33
  • 52 Week High: $410.00
  • 52 Week Low: $274.70
  • Currency: US Dollars
  • Shares Issued: 43.56m
  • Volume: 579,516
  • Market Cap: $13,492m
  • RiskGrade: 132

Latest ShareCast News

GlaxoSmithKline reportedly running the ruler over US rival

By Alexander Bueso

Date: Friday 04 Aug 2017

(ShareCast News) - GlaxoSmithKline may be studying a possible bid for US rival United Therapeutics, The Evening Standard reported citing City sources.

UTHR ShareCast News

No recent information was found.

UTHR Newspaper Links

Contracting 06-Dec-2007 Washington Post
United Therapeutics Shares Soar on FDA Report 02-Nov-2007 Washington Post
Study Raises Questions For United Therapeutics 27-Feb-2007 Washington Post
United Therapeutics Says Profit Plummets 70 Perc... 03-May-2006 Washington Post
United Therapeutics' Profit Surges 22-Feb-2006 Washington Post

UTHR Tips & Analysis

Test of Insomnia Drug Bolsters Vanda's Plan 16-Nov-2006 Washington Post
2005 Compensation For Top-Earning Executives Gre... 10-Jul-2006 Washington Post

UTHR News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

UTHR Market Data

Currency US Dollars
Share Price $ 309.72
Change Today $ 8.33
% Change 2.76 %
52 Week High $410.00
52 Week Low $274.70
Volume 579,516
Shares Issued 43.56m
Market Cap $13,492m
RiskGrade 132

What The Brokers Say

Strong Buy 6
Buy 4
Neutral 5
Sell 0
Strong Sell 0
Total 15
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 13-Aug-2025

Time Volume / Share Price
16:00 63,872 @ $309.72
15:59 100 @ $309.83
15:59 100 @ $310.04
15:59 100 @ $310.02
15:59 100 @ $309.92

Top of Page